Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.
GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis.
Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals.
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.
Common and Divergent Features of T Cells from Blood, Gut, and Genital Tract of Antiretroviral Therapy-Treated HIV+ Women
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.